| Year |
Citation |
Score |
| 2013 |
Nishi H, Tyagi M, Teng S, Shoemaker BA, Hashimoto K, Alexov E, Wuchty S, Panchenko AR. Cancer missense mutations alter binding properties of proteins and their interaction networks. Plos One. 8: e66273. PMID 23799087 DOI: 10.1371/Journal.Pone.0066273 |
0.662 |
|
| 2013 |
Nishi H, Hashimoto K, Madej T, Panchenko AR. Evolutionary, physicochemical, and functional mechanisms of protein homooligomerization. Progress in Molecular Biology and Translational Science. 117: 3-24. PMID 23663963 DOI: 10.1016/B978-0-12-386931-9.00001-5 |
0.727 |
|
| 2012 |
Hashimoto K, Rogozin IB, Panchenko AR. Oncogenic potential is related to activating effect of cancer single and double somatic mutations in receptor tyrosine kinases. Human Mutation. 33: 1566-75. PMID 22753356 DOI: 10.1002/Humu.22145 |
0.605 |
|
| 2012 |
Tyagi M, Hashimoto K, Shoemaker BA, Wuchty S, Panchenko AR. Large-scale mapping of human protein interactome using structural complexes. Embo Reports. 13: 266-71. PMID 22261719 DOI: 10.1038/Embor.2011.261 |
0.697 |
|
| 2011 |
Nishi H, Hashimoto K, Panchenko AR. Phosphorylation in protein-protein binding: effect on stability and function. Structure (London, England : 1993). 19: 1807-15. PMID 22153503 DOI: 10.1016/J.Str.2011.09.021 |
0.7 |
|
| 2011 |
Hashimoto K, Nishi H, Bryant S, Panchenko AR. Caught in self-interaction: evolutionary and functional mechanisms of protein homooligomerization. Physical Biology. 8: 035007. PMID 21572178 DOI: 10.1088/1478-3975/8/3/035007 |
0.729 |
|
| 2010 |
Hashimoto K, Panchenko AR. Mechanisms of protein oligomerization, the critical role of insertions and deletions in maintaining different oligomeric states. Proceedings of the National Academy of Sciences of the United States of America. 107: 20352-7. PMID 21048085 DOI: 10.1073/Pnas.1012999107 |
0.716 |
|
| 2010 |
Hashimoto K, Madej T, Bryant SH, Panchenko AR. Functional states of homooligomers: insights from the evolution of glycosyltransferases. Journal of Molecular Biology. 399: 196-206. PMID 20381499 DOI: 10.1016/J.Jmb.2010.03.059 |
0.653 |
|
| Low-probability matches (unlikely to be authored by this person) |
| 2020 |
Kajihara D, Hon CC, Abdullah AN, Wosniak J, Moretti AIS, Poloni JF, Bonatto D, Hashimoto K, Carninci P, Laurindo FRM. Analysis of splice variants of the human protein disulfide isomerase (P4HB) gene. Bmc Genomics. 21: 766. PMID 33148170 DOI: 10.1186/s12864-020-07164-y |
0.281 |
|
| 2012 |
Izumi Y, Li J, Villers C, Hashimoto K, Burg MB, Ferraris JD. Mutations that reduce its specific DNA binding inhibit high NaCl-induced nuclear localization of the osmoprotective transcription factor NFAT5. American Journal of Physiology. Cell Physiology. 303: C1061-9. PMID 22992674 DOI: 10.1152/ajpcell.00265.2012 |
0.259 |
|
| 2023 |
Koyama K, Hashimoto K, Nagao C, Mizuguchi K. Attention network for predicting T-cell receptor-peptide binding can associate attention with interpretable protein structural properties. Frontiers in Bioinformatics. 3: 1274599. PMID 38170146 DOI: 10.3389/fbinf.2023.1274599 |
0.256 |
|
| 2003 |
Kawano S, Okuno Y, Hashimoto K, Yamamoto H, Takematsu H, Kozutsumi Y, Goto S, Kanehisa M. Prediction of Glycan Structures from Glycosyltransferase Expression Profiles Genome Informatics. 14: 304-305. DOI: 10.11234/Gi1990.14.304 |
0.242 |
|
| 2022 |
Hashimoto K, Morisawa Y, Tortora M, Rossi B, Ozaki Y, Sato H. Attenuated Total Reflection Far-Ultraviolet (ATR Far-UV) Spectroscopy as a Sensitive Tool for the Investigation of Protein Adsorption. Applied Spectroscopy. 37028211070835. PMID 35081773 DOI: 10.1177/00037028211070835 |
0.24 |
|
| 2021 |
Hashimoto K, Jouhilahti EM, Töhönen V, Carninci P, Kere J, Katayama S. Embryonic LTR retrotransposons supply promoter modules to somatic tissues. Genome Research. 31: 1983-1993. PMID 34675070 DOI: 10.1101/gr.275354.121 |
0.24 |
|
| 2006 |
Hashimoto K, Goto S, Kawano S, Aoki-Kinoshita KF, Ueda N, Hamajima M, Kawasaki T, Kanehisa M. KEGG as a glycome informatics resource Glycobiology. 16: 63R-70R. PMID 16014746 DOI: 10.1093/Glycob/Cwj010 |
0.236 |
|
| 2004 |
Hizukuri Y, Yamanishi Y, Hashimoto K, Kanehisa M. Extraction of species-specific glycan substructures Genome Informatics. International Conference On Genome Informatics. 15: 69-81. PMID 15712111 DOI: 10.11234/Gi1990.15.69 |
0.234 |
|
| 2022 |
Vuoristo S, Bhagat S, Hydén-Granskog C, Yoshihara M, Gawriyski L, Jouhilahti EM, Ranga V, Tamirat M, Huhtala M, Kirjanov I, Nykänen S, Krjutškov K, Damdimopoulos A, Weltner J, Hashimoto K, et al. is a multifunctional factor priming human embryonic genome activation. Iscience. 25: 104137. PMID 35402882 DOI: 10.1016/j.isci.2022.104137 |
0.219 |
|
| 2017 |
Ishigaki M, Hashimoto K, Sato H, Ozaki Y. Non-destructive monitoring of mouse embryo development and its qualitative evaluation at the molecular level using Raman spectroscopy. Scientific Reports. 7: 43942. PMID 28272511 DOI: 10.1038/srep43942 |
0.203 |
|
| 2019 |
Watanabe K, Liu Y, Noguchi S, Murray M, Chang JC, Kishima M, Nishimura H, Hashimoto K, Minoda A, Suzuki H. OVOL2 induces mesenchymal-to-epithelial transition in fibroblasts and enhances cell-state reprogramming towards epithelial lineages. Scientific Reports. 9: 6490. PMID 31019211 DOI: 10.1038/s41598-019-43021-z |
0.197 |
|
| 2016 |
Kaczkowski B, Hashimoto K, Carninci P. Epi-drivers and cancer-testis genes Translational Cancer Research. 5: 334-336. DOI: 10.21037/8232 |
0.196 |
|
| 2022 |
Takano J, Ito S, Dong Y, Sharif J, Nakajima-Takagi Y, Umeyama T, Han YW, Isono K, Kondo T, Iizuka Y, Miyai T, Koseki Y, Ikegaya M, Sakihara M, Nakayama M, ... ... Hashimoto K, et al. PCGF1-PRC1 links chromatin repression with DNA replication during hematopoietic cell lineage commitment. Nature Communications. 13: 7159. PMID 36443290 DOI: 10.1038/s41467-022-34856-8 |
0.189 |
|
| 2020 |
Ramilowski JA, Yip CW, Agrawal S, Chang JC, Ciani Y, Kulakovskiy IV, Mendez M, Ooi JLC, Ouyang JF, Parkinson N, Petri A, Roos L, Severin J, Yasuzawa K, Abugessaisa I, ... ... Hashimoto K, et al. Functional annotation of human long noncoding RNAs via molecular phenotyping. Genome Research. PMID 32718982 DOI: 10.1101/Gr.254219.119 |
0.18 |
|
| 2005 |
Hashimoto K, Kawano S, Goto S, Aoki-Kinoshita KF, Kawashima M, Kanehisa M. A global representation of the carbohydrate structures: a tool for the analysis of glycan. Genome Informatics. International Conference On Genome Informatics. 16: 214-22. PMID 16362924 DOI: 10.11234/Gi1990.16.214 |
0.178 |
|
| 2006 |
Binder B, Ebenhöh O, Hashimoto K, Heinrich R. Expansion of signal transduction networks. Systems Biology. 153: 364-8. PMID 16986318 DOI: 10.1049/ip-syb:20060030 |
0.178 |
|
| 2019 |
Pawlak M, Kedzierska KZ, Migdal M, Nahia KA, Ramilowski JA, Bugajski L, Hashimoto K, Marconi A, Piwocka K, Carninci P, Winata CL. Dynamics of cardiomyocyte transcriptome and chromatin landscape demarcates key events of heart development. Genome Research. PMID 30760547 DOI: 10.1101/Gr.244491.118 |
0.176 |
|
| 2009 |
Hashimoto K, Tokimatsu T, Kawano S, Yoshizawa AC, Okuda S, Goto S, Kanehisa M. Comprehensive analysis of glycosyltransferases in eukaryotic genomes for structural and functional characterization of glycans. Carbohydrate Research. 344: 881-7. PMID 19327755 DOI: 10.1016/J.Carres.2009.03.001 |
0.169 |
|
| 2015 |
Fort A, Yamada D, Hashimoto K, Koseki H, Carninci P. Nuclear transcriptome profiling of induced pluripotent stem cells and embryonic stem cells identify non-coding loci resistant to reprogramming. Cell Cycle (Georgetown, Tex.). 14: 1148-55. PMID 25664506 DOI: 10.4161/15384101.2014.988031 |
0.166 |
|
| 2020 |
Bonetti A, Agostini F, Suzuki AM, Hashimoto K, Pascarella G, Gimenez J, Roos L, Nash AJ, Ghilotti M, Cameron CJF, Valentine M, Medvedeva YA, Noguchi S, Agirre E, Kashi K, et al. RADICL-seq identifies general and cell type-specific principles of genome-wide RNA-chromatin interactions. Nature Communications. 11: 1018. PMID 32094342 DOI: 10.1038/S41467-020-14337-6 |
0.166 |
|
| 2021 |
Kobayashi K, Kaira K, Iemura H, Shinomiya S, Hashimoto K, Miura Y, Shiono A, Nishihara F, Kagamu H. Combination of immune check inhibitor and immunomodulatory arabinomannan extracted from : A case report. Molecular and Clinical Oncology. 15: 227. PMID 34631053 DOI: 10.3892/mco.2021.2390 |
0.165 |
|
| 2023 |
Kaira K, Imai H, Mouri A, Hashimoto K, Miura Y, Shiono A, Yamaguchi O, Kobayashi K, Kawasaki T, Yasuda M, Kagamu H. Clinicopathological impact of VEGFR2 and VEGF-C in patients with EGFR-major mutant NSCLC receiving osimertinib. Thoracic Cancer. PMID 37605832 DOI: 10.1111/1759-7714.15082 |
0.157 |
|
| 2014 |
Fort A, Hashimoto K, Yamada D, Salimullah M, Keya CA, Saxena A, Bonetti A, Voineagu I, Bertin N, Kratz A, Noro Y, Wong CH, de Hoon M, Andersson R, Sandelin A, et al. Deep transcriptome profiling of mammalian stem cells supports a regulatory role for retrotransposons in pluripotency maintenance. Nature Genetics. 46: 558-66. PMID 24777452 DOI: 10.1038/Ng.2965 |
0.156 |
|
| 2007 |
Suga A, Yamanishi Y, Hashimoto K, Goto S, Kanehisa M. An improved scoring scheme for predicting glycan structures from gene expression data. Genome Informatics. International Conference On Genome Informatics. 18: 237-46. PMID 18546491 DOI: 10.11234/Gi1990.18.237 |
0.152 |
|
| 2022 |
Pascarella G, Hon CC, Hashimoto K, Busch A, Luginbühl J, Parr C, Hin Yip W, Abe K, Kratz A, Bonetti A, Agostini F, Severin J, Murayama S, Suzuki Y, Gustincich S, et al. Recombination of repeat elements generates somatic complexity in human genomes. Cell. 185: 3025-3040.e6. PMID 35882231 DOI: 10.1016/j.cell.2022.06.032 |
0.15 |
|
| 2020 |
Yamaguchi O, Kaira K, Kawasaki T, Mouri A, Hashimoto K, Shiono A, Shinomiya S, Miura Y, Nishihara F, Murayama Y, Kobayashi K, Mochida S, Kagamu H. Severe hepatotoxicity due to osimertinib after nivolumab therapy in patients with non-small cell lung cancer harboring EGFR mutation. Thoracic Cancer. PMID 32068351 DOI: 10.1111/1759-7714.13363 |
0.145 |
|
| 2010 |
Hashimoto K, Kanehisa M. KEGG GLYCAN for integrated analysis of pathways, genes, and glycan structures Handbook of Glycomics. 197-210. DOI: 10.1016/B978-0-12-373600-0.00009-3 |
0.145 |
|
| 2019 |
Yamaguchi O, Kaira K, Mouri A, Shiono A, Hashimoto K, Miura Y, Nishihara F, Murayama Y, Kobayashi K, Kagamu H. Re-challenge of afatinib after 1st generation EGFR-TKI failure in patients with previously treated non-small cell lung cancer harboring EGFR mutation. Cancer Chemotherapy and Pharmacology. PMID 30758646 DOI: 10.1007/s00280-019-03790-w |
0.143 |
|
| 2008 |
Hashimoto K, Yoshizawa AC, Okuda S, Kuma K, Goto S, Kanehisa M. The repertoire of desaturases and elongases reveals fatty acid variations in 56 eukaryotic genomes. Journal of Lipid Research. 49: 183-91. PMID 17921532 DOI: 10.1194/Jlr.M700377-Jlr200 |
0.132 |
|
| 2015 |
Tebbi A, Levillayer F, Jouvion G, Fiette L, Soubigou G, Varet H, Boudjadja N, Cairo S, Hashimoto K, Suzuki AM, Carninci P, Carissimo A, di Bernado D, Wei Y. Deficiency of multidrug resistance 2 contributes to cell transformation through oxidative stress. Carcinogenesis. PMID 26542370 DOI: 10.1093/Carcin/Bgv156 |
0.13 |
|
| 2019 |
Yamaguchi O, Kaira K, Mouri A, Shiono A, Hashimoto K, Miura Y, Nishihara F, Murayama Y, Kobayashi K, Kagamu H. Correction to: Re-challenge of afatinib after 1st generation EGFR-TKI failure in patients with previously treated non-small cell lung cancer harboring EGFR mutation. Cancer Chemotherapy and Pharmacology. PMID 31705267 DOI: 10.1007/s00280-019-03984-2 |
0.13 |
|
| 2021 |
Bonetti A, Agostini F, Suzuki AM, Hashimoto K, Pascarella G, Gimenez J, Roos L, Nash AJ, Ghilotti M, Cameron CJF, Valentine M, Medvedeva YA, Noguchi S, Agirre E, Kashi K, et al. Author Correction: RADICL-seq identifies general and cell type-specific principles of genome-wide RNA-chromatin interactions. Nature Communications. 12: 3128. PMID 34011993 DOI: 10.1038/s41467-021-23542-w |
0.129 |
|
| 2008 |
Hashimoto K, Takigawa I, Shiga M, Kanehisa M, Mamitsuka H. Mining significant tree patterns in carbohydrate sugar chains. Bioinformatics (Oxford, England). 24: i167-73. PMID 18689820 DOI: 10.1093/bioinformatics/btn293 |
0.125 |
|
| 2015 |
Taguchi A, Nagasaka K, Kawana K, Hashimoto K, Kusumoto-Matsuo R, Plessy C, Thomas M, Nakamura H, Bonetti A, Oda K, Kukimoto I, Carninci P, Banks L, Osuga Y, Fujii T. Characterization of novel transcripts of human papillomavirus type 16 using cap analysis gene expression technology. Journal of Virology. 89: 2448-52. PMID 25505068 DOI: 10.1128/Jvi.03433-14 |
0.124 |
|
| 2003 |
Hashimoto K, Hamajima M, Goto S, Masumoto S, Kawasima M, Kanehisa M. GLYCAN: The Database of Carbohydrate Structures Genome Informatics. 14: 649-650. DOI: 10.11234/Gi1990.14.649 |
0.122 |
|
| 2024 |
Hashimoto K, Miwa T, Ono C, Nara K, Mutai H, Seto T, Sakamoto H, Matsunaga T. Gap Junction Beta-2 p.Val84Met Can Cause Autosomal Dominant Syndromic Hearing Loss With Keratoderma. Cureus. 16: e54992. PMID 38550477 DOI: 10.7759/cureus.54992 |
0.12 |
|
| 2024 |
Hashimoto K, Kaira K, Imai H, Miura YU, Shiono A, Mouri A, Yamaguchi OU, Kobayashi K, Kagamu H, Kuji I. Metabolic Tumor Volume as Significant Predictor for Chemotherapy Containing PD-L1 Blocker in Extensive Stage Small Cell Lung Cancer. Anticancer Research. 44: 1541-1551. PMID 38537960 DOI: 10.21873/anticanres.16951 |
0.12 |
|
| 2006 |
Hashimoto K, Yoshizawa AC, Saito K, Yamada T, Kanehisa M. The repertoire of desaturases for unsaturated fatty acid synthesis in 397 genomes. Genome Informatics. International Conference On Genome Informatics. 17: 173-83. PMID 17503367 DOI: 10.11234/Gi1990.17.173 |
0.118 |
|
| 2005 |
Kawano S, Hashimoto K, Miyama T, Goto S, Kanehisa M. Prediction of glycan structures from gene expression data based on glycosyltransferase reactions. Bioinformatics (Oxford, England). 21: 3976-82. PMID 16159923 DOI: 10.1093/Bioinformatics/Bti666 |
0.117 |
|
| 2022 |
Hayakawa M, Taylor JN, Nakao R, Mochizuki K, Sawai Y, Hashimoto K, Tabata K, Kumamoto Y, Fujita K, Konishi E, Hirano S, Tanaka H, Komatsuzaki T, Harada Y. Lipid droplet accumulation and adipophilin expression in follicular thyroid carcinoma. Biochemical and Biophysical Research Communications. 640: 192-201. PMID 36521425 DOI: 10.1016/j.bbrc.2022.12.007 |
0.117 |
|
| 2015 |
Hashimoto K, Suzuki AM, Dos Santos A, Desterke C, Collino A, Ghisletti S, Braun E, Bonetti A, Fort A, Qin XY, Radaelli E, Kaczkowski B, Forrest AR, Kojima S, Samuel D, et al. CAGE profiling of ncRNAs in hepatocellular carcinoma reveals widespread activation of retroviral LTR promoters in virus-induced tumors. Genome Research. PMID 26510915 DOI: 10.1101/Gr.191031.115 |
0.116 |
|
| 2020 |
Abugessaisa I, Ramilowski JA, Lizio M, Severin J, Hasegawa A, Harshbarger J, Kondo A, Noguchi S, Yip CW, Ooi JLC, Tagami M, Hori F, Agrawal S, Hon CC, Cardon M, ... ... Hashimoto K, et al. FANTOM enters 20th year: expansion of transcriptomic atlases and functional annotation of non-coding RNAs. Nucleic Acids Research. PMID 33211864 DOI: 10.1093/nar/gkaa1054 |
0.115 |
|
| 2019 |
Yamanaka S, Nishihara H, Toh H, Eijy Nagai LA, Hashimoto K, Park SJ, Shibuya A, Suzuki AM, Tanaka Y, Nakai K, Carninci P, Sasaki H, Siomi H. Broad Heterochromatic Domains Open in Gonocyte Development Prior to De Novo DNA Methylation. Developmental Cell. PMID 31474564 DOI: 10.1016/J.Devcel.2019.07.023 |
0.108 |
|
| 2019 |
Taylor JN, Mochizuki K, Hashimoto K, Kumamoto Y, Harada Y, Fujita K, Komatsuzaki T. High-Resolution Raman Microscopic Detection of Follicular Thyroid Cancer Cells with Unsupervised Machine Learning. The Journal of Physical Chemistry. B. PMID 31035762 DOI: 10.1021/acs.jpcb.9b01159 |
0.105 |
|
| 2020 |
Ramilowski JA, Yip CW, Agrawal S, Chang J, Ciani Y, Kulakovskiy IV, Mendez M, Ooi JLC, Ouyang JF, Parkinson N, Petri A, Roos L, Severin J, Yasuzawa K, Abugessaisa I, ... ... Hashimoto K, et al. Corrigendum: Functional annotation of human long noncoding RNAs via molecular phenotyping Genome Research. 30: 1377-1-1377-1. DOI: 10.1101/Gr.270330.120 |
0.101 |
|
| 2016 |
Altinel K, Hashimoto K, Wei Y, Neuveut C, Gupta I, Suzuki AM, Dos Santos A, Moreau P, Xia T, Kojima S, Kato S, Takikawa Y, Hidaka I, Shimizu M, Matsuura T, et al. Single-nucleotide-resolution mapping of HBV promoters in infected human livers and hepatocellular carcinoma. Journal of Virology. PMID 27681123 DOI: 10.1128/Jvi.01625-16 |
0.101 |
|
| 2008 |
Hashimoto K, Aoki-Kinoshita KF, Ueda N, Kanehisa M, Mamitsuka H. A new efficient probabilistic model for mining labeled ordered trees applied to glycobiology Acm Transactions On Knowledge Discovery From Data. 2. DOI: 10.1145/1342320.1342326 |
0.099 |
|
| 2022 |
Yamaguchi O, Atarashi K, Yoshimura K, Shiono A, Mouri A, Nishihara F, Miura Y, Hashimoto K, Miyamoto Y, Uga H, Seki N, Matsushima T, Kikukawa N, Kobayashi K, Kaira K, et al. Establishing a whole blood CD4 T cell immunity measurement to predict response to anti-PD-1. Bmc Cancer. 22: 1325. PMID 36528575 DOI: 10.1186/s12885-022-10445-2 |
0.095 |
|
| 2023 |
Yanagihara A, Yamasaki S, Hashimoto K, Taguchi R, Umesaki T, Imai H, Kaira K, Nitanda H, Sakaguchi H, Ishida H, Kobayashi K, Horimoto K, Kagamu H. A Th1-like CD4 T-cell Cluster That Predicts Disease-free Survival in Early-stage Lung Cancer. Cancer Research Communications. 3: 1277-1285. PMID 37476074 DOI: 10.1158/2767-9764.CRC-23-0167 |
0.087 |
|
| 2023 |
Watanabe R, Hashimoto K, Higashisaka K, Haga Y, Tsutsumi Y, Mizuguchi K. Evidence-Based Prediction of Cellular Toxicity for Amorphous Silica Nanoparticles. Acs Nano. 17: 9987-9999. PMID 37254442 DOI: 10.1021/acsnano.2c11968 |
0.086 |
|
| 2021 |
Kaira K, Kobayashi K, Shiono A, Yamaguchi O, Hashimoto K, Mouri A, Shinomiya S, Miura Y, Imai H, Kagamu H. Effectiveness of EGFR-TKI rechallenge immediately after PD-1 blockade failure. Thoracic Cancer. PMID 33522139 DOI: 10.1111/1759-7714.13864 |
0.084 |
|
| 2020 |
Taguchi A, Nagasaka K, Plessy C, Nakamura H, Kawata Y, Kato S, Hashimoto K, Nagamatsu T, Oda K, Kukimoto I, Kawana K, Carninci P, Osuga Y, Fujii T. Use of Cap Analysis Gene Expression to detect human papillomavirus promoter activity patterns at different disease stages. Scientific Reports. 10: 17991. PMID 33093512 DOI: 10.1038/s41598-020-75133-2 |
0.084 |
|
| 2019 |
Yamaguchi O, Kaira K, Hashimoto K, Mouri A, Miura Y, Shiono A, Nishihara F, Murayama Y, Noda SE, Kato S, Kobayashi K, Kagamu H. Radiotherapy is an independent prognostic marker of favorable prognosis in non-small cell lung cancer patients after treatment with the immune checkpoint inhibitor, nivolumab. Thoracic Cancer. PMID 30888716 DOI: 10.1111/1759-7714.13044 |
0.083 |
|
| 2008 |
Hashimoto K, Goto S, Kanehisa M. [KEGG GLYCAN and glycome informatics]. Tanpakushitsu Kakusan Koso. Protein, Nucleic Acid, Enzyme. 53: 1698-702. PMID 21089391 |
0.083 |
|
| 2023 |
Yamaguchi O, Kaira K, Imai H, Mouri A, Shiono A, Miura Y, Hashimoto K, Kobayashi K, Kagamu H. Clinical utility of inflammatory and nutritious index as therapeutic prediction of nivolumab plus ipilimumab in advanced NSCLC. Oncology. PMID 37725914 DOI: 10.1159/000534169 |
0.08 |
|
| 2018 |
Qin XY, Suzuki H, Honda M, Okada H, Kaneko S, Inoue I, Ebisui E, Hashimoto K, Carninci P, Kanki K, Tatsukawa H, Ishibashi N, Masaki T, Matsuura T, Kagechika H, et al. Prevention of hepatocellular carcinoma by targeting MYCN-positive liver cancer stem cells with acyclic retinoid. Proceedings of the National Academy of Sciences of the United States of America. PMID 29686061 DOI: 10.1073/Pnas.1802279115 |
0.078 |
|
| 2022 |
Hashimoto K, Kaira K, Imai H, Mouri A, Shiono A, Miura Y, Yamaguchi O, Kobayashi K, Kagamu H, Kuji I. Prognostic Potential of Metabolic Activity on 18F-FDG Accumulation in Advanced NSCLC Receiving Combining Chemotherapy Plus PD-1 Blockade. Journal of Immunotherapy (Hagerstown, Md. : 1997). PMID 35980360 DOI: 10.1097/CJI.0000000000000434 |
0.077 |
|
| 2021 |
Paramitha PN, Zakaria R, Maryani A, Kusaka Y, Andriana BB, Hashimoto K, Nakazawa H, Kato S, Sato H. Raman Study on Lipid Droplets in Hepatic Cells Co-Cultured with Fatty Acids. International Journal of Molecular Sciences. 22. PMID 34298998 DOI: 10.3390/ijms22147378 |
0.075 |
|
| 2015 |
Konno D, Kasukawa T, Hashimoto K, Itoh T, Suetsugu T, Miura I, Wakana S, Carninci P, Matsuzaki F. STAP cells are derived from ES cells. Nature. 525: E4-5. PMID 26399834 DOI: 10.1038/Nature15366 |
0.073 |
|
| 2017 |
de Rie D, Abugessaisa I, Alam T, Arner E, Arner P, Ashoor H, Åström G, Babina M, Bertin N, Burroughs AM, Carlisle AJ, Daub CO, Detmar M, Deviatiiarov R, Fort A, ... ... Hashimoto K, et al. An integrated expression atlas of miRNAs and their promoters in human and mouse. Nature Biotechnology. PMID 28829439 DOI: 10.1038/Nbt.3947 |
0.072 |
|
| 2022 |
Kagamu H, Yamasaki S, Kitano S, Yamaguchi O, Mouri A, Shiono A, Nishihara F, Miura Y, Hashimoto K, Imai H, Kaira K, Kobayashi K, Kanai Y, Shibata T, Horimoto K. Single-cell analysis reveals a CD4+ T cell cluster that correlates with PD-1 blockade efficacy. Cancer Research. PMID 36219677 DOI: 10.1158/0008-5472.CAN-22-0112 |
0.071 |
|
| 2019 |
Mouri A, Kaira K, Yamaguchi O, Shiono A, Miura Y, Hashimoto K, Nishihara F, Murayama Y, Kobayashi K, Kagamu H. Clinical difference between discontinuation and retreatment with nivolumab after immune-related adverse events in patients with lung cancer. Cancer Chemotherapy and Pharmacology. PMID 31444618 DOI: 10.1007/s00280-019-03926-y |
0.07 |
|
| 2022 |
Hashimoto K, Ide S, Arata M, Nakata A, Ito A, Ito TK, Kudo N, Lin B, Nunomura K, Tsuganezawa K, Yoshida M, Nagaoka Y, Sumiyoshi T. Discovery of Benzylpiperazine Derivatives as CNS-Penetrant and Selective Histone Deacetylase 6 Inhibitors. Acs Medicinal Chemistry Letters. 13: 1077-1082. PMID 35859864 DOI: 10.1021/acsmedchemlett.2c00081 |
0.07 |
|
| 2023 |
Mouri A, Kaira K, Yamaguchi O, Hashimoto K, Miura Y, Shiono A, Kawasaki T, Kobayashi K, Imai H, Kagamu H. Clinical significance of antinuclear antibody as prognostic marker for first-line pembrolizumab in advanced non-small cell lung cancer. International Journal of Clinical Oncology. PMID 38160406 DOI: 10.1007/s10147-023-02445-4 |
0.069 |
|
| 2019 |
Uchida T, Kaira K, Yamaguchi O, Mouri A, Shiono A, Miura Y, Hashimoto K, Nishihara F, Murayama Y, Kobayashi K, Kagamu H. Different incidence of interstitial lung disease according to different kinds of EGFR-tyrosine kinase inhibitors administered immediately before and/or after anti-PD-1 antibodies in lung cancer. Thoracic Cancer. PMID 30864291 DOI: 10.1111/1759-7714.13039 |
0.069 |
|
| 2019 |
Kumamoto Y, Mochizuki K, Hashimoto K, Harada Y, Tanaka H, Fujita K. High-Throughput Cell Imaging and Classification by Narrowband and Low-Spectral-Resolution Raman Microscopy. The Journal of Physical Chemistry. B. PMID 30830787 DOI: 10.1021/acs.jpcb.8b11295 |
0.068 |
|
| 2015 |
Nagasaka K, Taguchi A, Kawana K, Hashimoto K, Plessy C, Nakamura H, Thomas M, Oda K, Kukimoto I, Carninci P, Banks L, Osuga Y, Fujii T. A new approach for screening cervical cancer by characterization of transcripts using CAGE technology. Journal of Clinical Oncology. 33: e16514-e16514. DOI: 10.1200/Jco.2015.33.15_Suppl.E16514 |
0.067 |
|
| 2020 |
Miura Y, Mouri A, Kaira K, Yamaguchi O, Shiono A, Hashimoto K, Nishihara F, Shinomiya S, Akagami T, Murayama Y, Abe T, Noda SE, Kato S, Kobayashi K, Kagamu H. Chemoradiotherapy followed by durvalumab in patients with unresectable advanced non-small cell lung cancer: Management of adverse events. Thoracic Cancer. PMID 32160383 DOI: 10.1111/1759-7714.13394 |
0.066 |
|
| 2021 |
Imai H, Yamaguchi O, Mori K, Hashimoto K, Akagami T, Shinomiya S, Miura Y, Shiono A, Mouri A, Kaira K, Kobayashi K, Kagamu H. Clinical impact of post-progression survival on overall survival in patients receiving nivolumab monotherapy as a second-line treatment for advanced non-small cell lung cancer. Thoracic Cancer. PMID 33626218 DOI: 10.1111/1759-7714.13886 |
0.065 |
|
| 2020 |
Yamaguchi O, Kaira K, Shinomiya S, Mouri A, Hashimoto K, Shiono A, Miura Y, Akagami T, Imai H, Kobayashi K, Kagamu H. Pre-existing interstitial lung disease does not affect prognosis in non-small cell lung cancer patients with PD-L1 expression ≥50% on first-line pembrolizumab. Thoracic Cancer. PMID 33185333 DOI: 10.1111/1759-7714.13725 |
0.063 |
|
| 2019 |
Valentine MNZ, Hashimoto K, Fukuhara T, Saiki S, Ishikawa KI, Hattori N, Carninci P. Multi-year whole-blood transcriptome data for the study of onset and progression of Parkinson's Disease. Scientific Data. 6: 20. PMID 30952910 DOI: 10.1038/S41597-019-0022-9 |
0.063 |
|
| 2022 |
Imai H, Naito E, Yamaguchi O, Hashimoto K, Iemura H, Miura Y, Shiono A, Mouri A, Kaira K, Kobayashi K, Kagamu H. Pretreatment body mass index predicts survival among patients administered nivolumab monotherapy for pretreated non-small cell lung cancer. Thoracic Cancer. PMID 35394119 DOI: 10.1111/1759-7714.14417 |
0.063 |
|
| 2023 |
Taylor JN, Pélissier A, Mochizuki K, Hashimoto K, Kumamoto Y, Harada Y, Fujita K, Bocklitz T, Komatsuzaki T. Correction for Extrinsic Background in Raman Hyperspectral Images. Analytical Chemistry. 95: 12298-12305. PMID 37561910 DOI: 10.1021/acs.analchem.3c01406 |
0.06 |
|
| 2019 |
Hashimoto K, Kouno T, Ikawa T, Hayatsu N, Miyajima Y, Yabukami H, Terooatea T, Sasaki T, Suzuki T, Valentine M, Pascarella G, Okazaki Y, Suzuki H, Shin JW, Minoda A, et al. Single-cell transcriptomics reveals expansion of cytotoxic CD4 T cells in supercentenarians. Proceedings of the National Academy of Sciences of the United States of America. PMID 31719197 DOI: 10.1073/Pnas.1907883116 |
0.058 |
|
| 2019 |
Shiono A, Kaira K, Mouri A, Yamaguchi O, Hashimoto K, Uchida T, Miura Y, Nishihara F, Murayama Y, Kobayashi K, Kagamu H. Improved efficacy of ramucirumab plus docetaxel after nivolumab failure in previously treated non-small cell lung cancer patients. Thoracic Cancer. PMID 30809973 DOI: 10.1111/1759-7714.12998 |
0.057 |
|
| 2020 |
Yamaguchi O, Kaira K, Hashimoto K, Mouri A, Shiono A, Miura Y, Murayama Y, Kobayashi K, Kagamu H, Kuji I. Tumor metabolic volume by F-FDG-PET as a prognostic predictor of first-line pembrolizumab for NSCLC patients with PD-L1 ≥ 50. Scientific Reports. 10: 14990. PMID 32929123 DOI: 10.1038/s41598-020-71735-y |
0.055 |
|
| 2023 |
Kaira K, Yamaguchi O, Naruse I, Umeda Y, Honda T, Watanabe S, Ichikawa K, Yanagisawa S, Kasahara N, Higuchi T, Hashimoto K, Miura Y, Shiono A, Mouri A, Imai H, et al. Comparative analysis of different response criteria at early phase after PD-1 blockade in non-small lung cancer. Cancer Imaging : the Official Publication of the International Cancer Imaging Society. 23: 23. PMID 36859341 DOI: 10.1186/s40644-023-00538-x |
0.054 |
|
| 2021 |
Mouri A, Kaira K, Yamaguchi O, Hashimoto K, Miura Y, Shiono A, Shinomiya S, Akagami T, Imai H, Kobayashi K, Kagamu H. Efficacy and Feasibility of Programmed Death-1/Programmed Death Ligand-1 Blockade Therapy in Non-Small Cell Lung Cancer Patients With High Antinuclear Antibody Titers. Frontiers in Oncology. 11: 610952. PMID 33791204 DOI: 10.3389/fonc.2021.610952 |
0.053 |
|
| 2019 |
Kagamu H, Kitano S, Yamaguchi O, Yoshimura K, Horimoto K, Kitazawa M, Fukui K, Shiono A, Mouri A, Nishihara F, Miura Y, Hashimoto K, Murayama Y, Kaira K, Kobayashi K. CD4+ T-cell immunity in the peripheral blood correlates with response to anti-PD-1 therapy. Cancer Immunology Research. PMID 31871122 DOI: 10.1158/2326-6066.Cir-19-0574 |
0.052 |
|
| 2020 |
Hashimoto K, Kaira K, Kawasaki T, Yamaguchi O, Kagamu H. Psuedoprogression mimicking hyperprogressive disease after pembrolizumab treatment in a patient with lung cancer. Lung Cancer (Amsterdam, Netherlands). 139: 221-223. PMID 31806361 DOI: 10.1016/j.lungcan.2019.11.019 |
0.05 |
|
| 2021 |
Hirai N, Maeda Y, Hashimoto K, Andriana BB, Matsuyoshi H, Sato H. EXPRESS: Coherent Anti-Stokes Raman Scattering Spectroscopy Using a Double-Wavelength-Emission Electronically Tuned Ti:Sapphire Laser. Applied Spectroscopy. 37028211020313. PMID 34041958 DOI: 10.1177/00037028211020313 |
0.047 |
|
| 2020 |
Pawlak M, Kedzierska KZ, Migdal M, Nahia KA, Ramilowski JA, Bugajski L, Hashimoto K, Marconi A, Piwocka K, Carninci P, Winata CL. Corrigendum: Dynamics of cardiomyocyte transcriptome and chromatin landscape demarcates key events of heart development Genome Research. 30: 153_2-153_2. DOI: 10.1101/Gr.260273.119 |
0.043 |
|
| 2022 |
Hashimoto K, Kaira K, Yamaguchi O, Shiono A, Mouri A, Miura Y, Kobayashi K, Imai H, Matsusaka Y, Kuji I, Kagamu H. Visual Assessment of 18F-FDG Uptake on PET to Predict Survival Benefit to PD-1 Blockade in Non-Small Cell Lung Cancer. Clinical Nuclear Medicine. 47: 108-116. PMID 35006104 DOI: 10.1097/RLU.0000000000004009 |
0.042 |
|
| 2015 |
Hashimoto K, Kudoh SN, Sato H. Analysis of the developing neural system using an in vitro model by Raman spectroscopy. The Analyst. 140: 2344-9. PMID 25610999 DOI: 10.1039/c4an01961j |
0.037 |
|
| 2018 |
Hashimoto K, Andriana BB, Matsuyoshi H, Sato H. Discrimination analysis of excitatory and inhibitory neurons using Raman spectroscopy. The Analyst. PMID 29796444 DOI: 10.1039/c8an00051d |
0.036 |
|
| 2012 |
Mouri H, Hori A, Kawashima Y, Hashimoto K. Large-scale length that determines the mean rate of energy dissipation in turbulence. Physical Review. E, Statistical, Nonlinear, and Soft Matter Physics. 86: 026309. PMID 23005856 |
0.035 |
|
| 2020 |
Hashimoto K, Kaira K, Yamaguchi O, Mouri A, Shiono A, Miura Y, Murayama Y, Kobayashi K, Kagamu H, Kuji I. Potential of FDG-PET as Prognostic Significance after anti-PD-1 Antibody against Patients with Previously Treated Non-Small Cell Lung Cancer. Journal of Clinical Medicine. 9. PMID 32156047 DOI: 10.3390/jcm9030725 |
0.034 |
|
| 2022 |
Yamaguchi O, Kaira K, Naruse I, Umeda Y, Honda T, Watanabe S, Ichikawa K, Tateishi K, Kasahara N, Higuchi T, Hashimoto K, Shinomiya S, Miura Y, Shiono A, Mouri A, et al. Prospective assessment using F-FDG PET/CT as a novel predictor for early response to PD-1 blockade in non-small-cell lung cancer. Scientific Reports. 12: 11832. PMID 35821395 DOI: 10.1038/s41598-022-15964-3 |
0.033 |
|
| 2021 |
Ikemoto K, Hashimoto K, Harada Y, Kumamoto Y, Hayakawa M, Mochizuki K, Matsuo K, Yashiro K, Yaku H, Takamatsu T, Tanaka H. Raman Spectroscopic Assessment of Myocardial Viability in Langendorff-Perfused Ischemic Rat Hearts. Acta Histochemica Et Cytochemica. 54: 65-72. PMID 34012178 DOI: JST.JSTAGE/ahc/21-00016 |
0.031 |
|
| 2022 |
Zakaria R, Andriana BB, Watanabe T, Maryani A, Paramitha PN, Kuntana YP, Kusaka Y, Noothalapati H, Iwasaki K, Oshima N, Hashimoto K, Matsuyoshi H, Ishihara S, Yamamoto T, Sato H. Development of in-situ Raman diagnosis technique of eosinophil esophagitis. Spectrochimica Acta. Part a, Molecular and Biomolecular Spectroscopy. 285: 121804. PMID 36122467 DOI: 10.1016/j.saa.2022.121804 |
0.031 |
|
| 2021 |
Naganuma K, Imai H, Yamaguchi O, Hashimoto K, Akagami T, Shinomiya S, Miura Y, Shiono A, Mouri A, Kaira K, Kobayashi K, Minato K, Kagamu H. Efficacy and Safety of Anti-Programed Death-1 Blockade in Previously Treated Large-Cell Neuroendocrine Carcinoma. Chemotherapy. 1-7. PMID 33827084 DOI: 10.1159/000514841 |
0.03 |
|
| 2021 |
Imai H, Kaira K, Hashimoto K, Nitanda H, Taguchi R, Yanagihara A, Umesaki T, Yamaguchi O, Mouri A, Kawasaki T, Yasuda M, Kobayashi K, Sakaguchi H, Kuji I, Kagamu H. Tumor immunity is related to F-FDG uptake in thymic epithelial tumor. Cancer Medicine. PMID 34363337 DOI: 10.1002/cam4.4176 |
0.03 |
|
| 2008 |
Hashimoto K, Morita A, Kuwahara S. Enantioselective synthesis of a mealybug pheromone with an irregular monoterpenoid skeleton. The Journal of Organic Chemistry. 73: 6913-5. PMID 18680345 DOI: 10.1021/jo801147c |
0.023 |
|
| 2022 |
Seki M, Hashimoto K, Kondo N, Ohya Y, Kotajima F, Mitsutake K. Sequential Treatment by Antiviral Drugs Followed by Immunosuppressive Agents for COVID-19 Patients with Hematological Malignancy. Infection and Drug Resistance. 15: 7117-7124. PMID 36506836 DOI: 10.2147/IDR.S393198 |
0.021 |
|
| 2019 |
Hashimoto K, Kaira K, Kobayashi K, Murayama Y, Kagamu H. Spontaneous aspiration of a long tree twig as foreign body. Respirology Case Reports. 7: e00401. PMID 30766681 DOI: 10.1002/rcr2.401 |
0.019 |
|
| 2017 |
Pawlak M, Kedzierska K, Bugajski L, Hashimoto K, Ramilowski J, Marconi A, Carninci P, Piwocka K, Winata C. Genomics dissection of the zebrafish heart Mechanisms of Development. 145: S143. DOI: 10.1016/J.Mod.2017.04.402 |
0.019 |
|
| 2022 |
Shiono A, Imai H, Satou T, Taguchi R, Takahashi N, Azuma R, Yamaguchi O, Hashimoto K, Naito E, Iemura H, Miura Y, Mouri A, Kaira K, Kobayashi K, Kagamu H. Metachronous lesions in the orbit, retroperitoneum, and pleura of mucosa-associated lymphoid tissue lymphoma: A case report. Cancer Reports (Hoboken, N.J.). e1689. PMID 35899993 DOI: 10.1002/cnr2.1689 |
0.018 |
|
| 2021 |
Yamaguchi O, Kaira K, Hashimoto K, Kagamu H. Detection of pseudoprogression with [F]-FDG-PET in a patient with pulmonary large cell neuroendocrine carcinoma who received anti-PD-1 treatment. European Journal of Nuclear Medicine and Molecular Imaging. 48: 1268-1270. PMID 33094431 DOI: 10.1007/s00259-020-05069-2 |
0.012 |
|
| Hide low-probability matches. |